Literature DB >> 29410124

Outcome of acute staphylococcal prosthetic joint infection treated with debridement, implant retention and antimicrobial treatment with short duration of rifampicin.

Henk Scheper1, Daphne van Hooven2, Michiel van de Sande3, Robert van der Wal3, Martha van der Beek4, Leo Visser2, Mark de Boer2, Rob Nelissen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29410124     DOI： 10.1016/j.jinf.2018.01.009

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  4 in total

1.  Debridement, Antibiotics, and Implant Retention with the Direct Anterior Approach for Acute Periprosthetic Joint Infection Following Primary THA.

Authors:  R L Deijkers; E P M van Elzakker; B G Pijls
Journal:  JB JS Open Access       Date:  2020-05-09

2.  If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study.

Authors:  Mark Beldman; Claudia Löwik; Alex Soriano; Laila Albiach; Wierd P Zijlstra; Bas A S Knobben; Paul Jutte; Ricardo Sousa; André Carvalho; Karan Goswami; Javad Parvizi; Katherine A Belden; Marjan Wouthuyzen-Bakker
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

3.  Effectiveness of Different Antimicrobial Strategies for Staphylococcal Prosthetic Joint Infection: Results From a Large Prospective Registry-Based Cohort Study.

Authors:  Henk Scheper; Robert J P van der Wal; Rachid Mahdad; Stefan Keizer; Nathalie M Delfos; Joris C T van der Lugt; Karin Ellen Veldkamp; Peter A Nolte; Masja Leendertse; Luc B S Gelinck; Femke P N Mollema; Emile F Schippers; Hanke G Wattel-Louis; Leo G Visser; Rob G H H Nelissen; Mark G J de Boer
Journal:  Open Forum Infect Dis       Date:  2022-09-13       Impact factor: 4.423

Review 4.  Outcome of Debridement, Antibiotics, and Implant Retention for Staphylococcal Hip and Knee Prosthetic Joint Infections, Focused on Rifampicin Use: A Systematic Review and Meta-Analysis.

Authors:  H Scheper; L M Gerritsen; B G Pijls; S A Van Asten; L G Visser; M G J De Boer
Journal:  Open Forum Infect Dis       Date:  2021-07-01       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.